Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERLOTINIB vs ERYTHROMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERLOTINIB vs ERYTHROMYCIN: Safety Overview

Metric ERLOTINIB ERYTHROMYCIN
Total FAERS Reports 22,472 7,325
Deaths Reported 6,791 467
Death Rate 30.2% 6.4%
Hospitalizations 3,693 1,213
Average Patient Age 67.2 yrs 53.9 yrs
% Female Patients 59.8% 79.8%
FDA Approval Date Apr 16, 2020 Approved Prior to Jan 1, 1982
Manufacturer Zydus Lifesciences Limited Bryant Ranch Prepack
Route ORAL TOPICAL
Marketing Status Discontinued Discontinued